BriaCell Therapeutics Corp. (NASDAQ:BCTX) filed a Form 8-K with the Securities and Exchange Commission on January 15, 2026, disclosing a material event.
BriaCell Therapeutics Corp.'s stock currently trades at $0.00 with a market capitalization of $0. The company's stock moved following the disclosure.
